Equities

Stemcell Holdings Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
STMM:PKL

Stemcell Holdings Inc

Actions
  • Price (USD)0.06
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jul 15 2020.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Stemcell Holdings, Inc. is engaged in the regenerative medicine-related business, which provides technical assistance to the culturing, storing and delivery of stem cells, administrative and consulting services to clinics. The Company provides two options for stem cell regenerative therapy: autologous adipose derived mesenchymal stem cells (ADMSC) and natural killer cells (NK). The Company provides coordination services to facilitate its stem cell culturing business. Its coordination services include the introduction of patients to clinics, arranging patients’ schedules, and translating between patients and clinics. The Company offers Internet marketing services by providing search engine optimization for clinics. It also offers property and equipment rental services. The Company operates through its wholly owned subsidiary, Stemcell Co., Ltd.

  • Revenue in USD (TTM)9.98m
  • Net income in USD3.10m
  • Incorporated2015
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Pure Harvest Corporate Group Inc2.48m-6.67m879.61k25.00--0.3903--0.3552-0.0901-0.09010.03830.02010.26441.4640.6499,070.40-70.96---136.76--33.83---268.37--0.5886-0.8660.7639--1,808.41---459.26------
ITonis Inc0.00-1.17m914.05k-----------0.0012-0.00120.00-0.00040.00-------187.63---1,169.36-------------0.8999---------506.86------
Vitalibis Inc243.57k-3.96m986.42k0.00------4.05-0.1103-0.11030.0034-0.00690.52010.352-----844.71-1,100.84----51.56---1,624.14-2,623.600.5512-2.33----490.69---207.18------
Evofem Biosciences Inc17.73m-5.56m1.15m32.00------0.065-0.058-0.0580.0111-0.56610.93922.253.61553,937.50-28.79-177.41----80.0569.60-30.66-602.270.0797-0.2439----6.28---117.93---38.87--
American Green Inc-100.00bn-100.00bn1.30m6.00------------------------------------------------------------
Procyon Corp4.98m-312.97k1.53m19.00--0.7027--0.307-0.0387-0.03870.61380.28171.472.329.90262,338.40-10.081.19-12.701.4478.0774.40-6.840.86912.41--0.00--6.353.53-367.38--17.32--
Stemcell Holdings Inc9.98m3.10m1.64m------0.50080.16450.000080.000080.00030.00021.12--5.20--34.90--68.19--77.19--31.04------0.00--85.10--71.82------
Panacea Life Sciences Holdings Inc2.76m-7.67m1.69m40.00------0.6102-0.4554-0.45540.164-0.52550.15371.6210.1369,098.25-42.65-69.04---225.03-139.49-181.62-277.51-505.410.0285-2.122.58--46.59--12.33------
Onconetix Inc1.22m-50.85m1.85m5.00--0.5504--1.51-350.74-350.742.142.160.031.3124.33244,750.00-120.44-82.49-240.72-114.7185.41---4,015.56-4,434.980.0706-17.940.0453--4,216.95---57.44--44.62--
Bio Essence Corp565.67k-160.45k2.08m2.00------3.67-0.0042-0.00420.0149-0.08161.26--16.06282,835.00-35.64-40.94----69.2838.36-28.36-134.00---57.42-------17.08-286.98------
Universe Pharmaceuticals Inc17.86m-3.67m2.24m216.00--0.0399--0.1254-10.13-10.1339.1899.640.26025.881.3882,679.35-5.35-5.40-7.08-7.0935.2843.33-20.56-9.653.90-17.460.1416---22.44-10.2757.92--46.30--
PRF Technologies Ltd0.00-4.09m2.33m2.000.00990.1421----301.27301.270.0020.970.00----0.00-57.27-71.03-118.06-84.02------------0.00-------56.12------
SOHM Inc-100.00bn-100.00bn2.44m--------------------------------------------------------------
Data as of Jul 15 2020. Currency figures normalised to Stemcell Holdings Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.